Generics' 2nd Challenge To Acne Drug IP Succeeds At PTAB
Handing a win to Amneal Pharmaceuticals and Mylan in a battle with Almirall LLC over a patent covering its acne drug Aczone, the Patent Trial and Appeal Board said the generics...To view the full article, register now.
Already a subscriber? Click here to view full article